A wide range of preclinical models of urological diseases.
An expertise on preclinical models for kidney pathologies
From cells and organoids to human tumors-xenografts models.
A wide range of preclinical models of gynecological diseases.
A wide range of preclinical models of males diseases.
An expertise on major gastrointestinal diseases.
With an optimized platform and a pharmaceutical industry level of quality, Urosphere’s Platform offers over a decade of expertise and know-how in preclinical drug development through its in vivo and in vitro models.
News & Publications
Experimental in vivo model to evaluate the impact of Cernitin™ on pain response on induced chronic bladder inflammation
Augé C. et al., 2022. Scandinavian Journal of Urology, 56 (4)
Integrated molecular and pharmacological characterization of patient derived xenografts from bladder and ureteral cancers identifies new potential therapies
Lang H. et al., 2022. Frontiers in Oncology, 12
June, 10-11 & 14-18, 2021 Location: Virtual
Research & Development
in 15 years
Models of urogenital diseases created by Urosphere
of our turnover is dedicated to
As a member of the drug discovery value chain, Urosphere can support your project. Our experts and platforms are dedicated to meeting your needs. Our aim is to understand your challenges and objectives to develop customized solutions together.